U.S. Food Stock News

NasdaqGS:SMCI
NasdaqGS:SMCITech

Super Micro Computer Q3 Margins At 3.7% Test Bullish Growth Narratives

Super Micro Computer (SMCI) just posted its Q3 2026 report with revenue of US$10.2b and basic EPS of US$0.81, setting the stage for investors to weigh top line scale against profit per share. The company has seen quarterly revenue range from US$5.0b in Q1 2026 to US$12.7b in Q2 2026, while basic EPS moved from US$0.18 in Q3 2025 to US$0.81 in the latest quarter, giving a clear view of how sales and earnings per share have tracked each other across recent periods. With trailing net profit...
NYSE:WEAV
NYSE:WEAVSoftware

Weave Communications Q1 Loss Reinforces Market Concerns About Prolonged Unprofitability

Weave Communications (WEAV) just posted its Q1 2026 numbers, with revenue of US$65.5 million, a basic EPS loss of US$0.07, and net income loss of US$5.77 million setting the tone for the quarter. Over the past year, the company has seen quarterly revenue move from US$55.8 million in Q1 2025 to US$65.5 million in Q1 2026, while basic EPS losses have ranged between roughly US$0.02 and US$0.12 per quarter. For you as an investor, the story this quarter is about a business adding revenue while...
NasdaqGS:FFIV
NasdaqGS:FFIVCommunications

F5 (FFIV) Net Margin At 22% Tests Bulls’ High‑Growth Narrative

F5 (FFIV) has put fresh numbers on the board for Q2 2026, reporting revenue of US$811.7 million and basic EPS of US$2.61, with trailing 12 month EPS at US$12.33 on revenue of US$3.2 billion. Over recent quarters the company has seen revenue move from US$731.1 million and EPS of US$2.51 in Q2 2025 to US$810.1 million and EPS of US$3.30 in Q4 2025, before landing at the latest Q2 2026 levels. This sets up the latest release as a check in on how earnings growth and margins are holding up. See...
NasdaqGS:HUT
NasdaqGS:HUTSoftware

Hut 8 (HUT) Q1 Loss Of US$219.8 Million Tests Bullish Growth Narratives

Hut 8 (HUT) opened 2026 with Q1 revenue of US$71.0 million, a basic EPS loss of US$1.98, and a net loss excluding extra items of US$219.8 million. On a trailing 12‑month basis, revenue stood at US$284.3 million and basic EPS was a loss of US$2.90 on a US$311.4 million net loss. Over recent quarters the company has seen revenue move from US$21.8 million in Q1 2025 to US$88.5 million in Q4 2025 before landing at US$71.0 million in Q1 2026. This came alongside basic EPS that has swung between a...
NYSE:HTGC
NYSE:HTGCCapital Markets

Hercules Capital (HTGC) Earnings Growth Slowdown Tests Bullish Margin Expansion Narrative

How Hercules Capital's Latest Numbers Set the Stage for the Current Debate Hercules Capital (HTGC) has opened 2026 with Q1 revenue of US$141.5 million and basic EPS of US$0.23, alongside trailing twelve month revenue of US$554.5 million and EPS of US$1.83 that reflect the strong 49.4% earnings growth recorded over the past year. Over recent quarters the company has seen revenue move from US$119.5 million in Q1 2025 to US$141.5 million in Q1 2026, with quarterly EPS ranging from US$0.29 to...
NYSE:UNM
NYSE:UNMInsurance

A Look At Unum Group (UNM) Valuation After Strong First Quarter Earnings And EPS Growth

Unum Group (UNM) has been in focus after reporting first quarter 2026 results, with revenue of US$3,355.2 million and net income of US$232 million, alongside higher earnings per share versus a year earlier. See our latest analysis for Unum Group. At a share price of US$80.29, Unum Group has seen a 30 day share price return of 5.87% and a 90 day share price return of 6.12%. Its 3 year total shareholder return of 96.88% and 5 year total shareholder return of 223.37% point to solid longer term...
NYSE:AMWL
NYSE:AMWLHealthcare Services

American Well Q1 Loss Improvement Reinforces Bullish Margin Narrative Despite Shrinking Revenue Base

American Well Q1 2026 earnings snapshot American Well (AMWL) opened 2026 with Q1 revenue of US$54.9 million and a basic EPS loss of US$0.66, alongside a trailing twelve month EPS loss of US$5.40 on revenue of US$237.4 million. The company reported a change in quarterly revenue from US$66.8 million in Q1 2025 to US$54.9 million in Q1 2026, while quarterly EPS losses across that period have ranged between about US$0.66 and US$2.77. These figures provide the context for assessing current...
NYSE:IQV
NYSE:IQVLife Sciences

IQVIA Holdings (IQV) Earnings Growth And 8.3% Margin Keep Backlog Narrative In Question

IQVIA Holdings (IQV) Q1 2026 earnings snapshot IQVIA Holdings (IQV) opened 2026 with Q1 revenue of about US$4.2b and basic EPS of US$1.63, setting the tone for how its earnings profile is evolving after a year in which trailing 12 month EPS came in at US$8.14 on revenue of about US$16.6b. Over the last five reported quarters, the company has seen quarterly revenue move from US$3.8b in Q1 2025 to US$4.2b in Q1 2026, while basic EPS across those prints has ranged between US$1.42 and US$3.02,...
NasdaqGS:SLAB
NasdaqGS:SLABSemiconductor

Silicon Laboratories (SLAB) Q1 Loss Narrows Challenging Long‑Running Bearish Profitability Narrative

Silicon Laboratories (SLAB) opened Q1 2026 with revenue of US$213.5 million and a basic EPS loss of US$0.48, as net income excluding extra items came in at a loss of US$15.9 million. The company has seen quarterly revenue move from US$166.2 million in Q4 2024 to US$177.7 million in Q1 2025, then to US$213.5 million in Q1 2026. Over the same quarters, EPS shifted from a loss of US$0.73 to a loss of US$0.94 and then to a loss of US$0.48. For investors, the key question is whether this top line...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Ultragenyx Pharmaceutical (RARE) Heavy Q1 EPS Loss Tests Bulls Profitability Timeline Narrative

Ultragenyx Pharmaceutical (RARE) opened Q1 2026 with revenue of US$136 million and basic EPS of US$1.84 loss, while trailing twelve month figures show revenue of US$670 million and basic EPS of US$6.11 loss. Over recent quarters, revenue has moved between US$139.3 million in Q1 2025 and US$207.3 million in Q4 2025, as basic EPS losses ranged from US$1.17 to US$1.81 per quarter. This gives investors a clear view of how top line growth is running ahead of earnings. For anyone watching margins...
NYSE:COR
NYSE:CORHealthcare

Cencora (COR) Valuation Check As Earnings Growth Follows Specialty Pharma And Acquisition Gains

Cencora (COR) just released its second quarter results, with sales of US$78.4b and net income of US$1.6b, drawing fresh attention to how the stock reflects its healthcare distribution and specialty pharma exposure. See our latest analysis for Cencora. The earnings release has arrived alongside a sharp reset in sentiment, with the share price at US$252.74 after a 1-day share price return decline of 17.38% and a 90-day share price return decline of 28.23%. However, the 5-year total shareholder...
NYSE:SWX
NYSE:SWXGas Utilities

Southwest Gas Holdings Q1 EPS Strength Tests Bullish Growth Narrative At Premium Valuation

Southwest Gas Holdings (SWX) opened 2026 with Q1 revenue of US$585.1 million and basic EPS of US$1.91, setting the tone for how investors may read the rest of the year. The company has seen quarterly revenue move from US$553.1 million in Q4 2024 to US$585.1 million in Q1 2026, while basic EPS has ranged from US$1.18 in Q4 2024 to US$1.91 in the latest quarter. This gives investors a clear view of how the top and bottom line are tracking as margins and profitability stay in focus. See our full...
NYSE:ALV
NYSE:ALVAuto Components

Is Autoliv (ALV) Pricing In Its Strong Multi‑Year Share Price Performance?

Investors may be wondering whether Autoliv stock now reflects its underlying value, or if the recent attention has left some mispricing on the table. The share price recently closed at US$121.25, with returns of 7.0% over 7 days, 15.2% over 30 days, 33.2% over 1 year, 49.8% over 3 years, 44.3% over 5 years and a small year to date loss of 0.7%. Recent coverage has focused on Autoliv as a key player in vehicle safety systems. This helps frame how investors are thinking about its earnings...
NasdaqGS:MTCH
NasdaqGS:MTCHInteractive Media and Services

Match Group (MTCH) Margin Improvement Challenges Cautious Earnings Narratives

Match Group (MTCH) opened 2026 with Q1 revenue of US$863.9 million and basic EPS of US$0.71, setting the tone for how the business is entering the new year. The company has seen quarterly revenue move from US$831.2 million and EPS of US$0.47 in Q1 2025 through a series of higher and lower prints over 2025 to the latest Q1 2026 figures, giving investors a fuller view of how the top and bottom lines have tracked over the last five reported quarters. With trailing 12 month EPS at US$2.78 and net...
NasdaqGS:SNEX
NasdaqGS:SNEXCapital Markets

Is It Too Late To Consider StoneX Group (SNEX) After Its Strong Recent Share Price Run?

Wondering whether StoneX Group stock still offers value after its strong run, or if you might be late to the party? This article breaks down what the current price could mean for you. At a recent close of US$106.39, the stock shows returns of 2.6% over 7 days, 24.3% over 30 days, 63.9% year to date and 69.5% over 1 year, with a very large 5 year return of 436.3%. Recent news coverage has focused on StoneX Group's role as a global financial services company and its position in capital...
NYSE:BXP
NYSE:BXPOffice REITs

A Look At Boston Properties (BXP) Valuation After Its Recent Share Price Rebound

Why BXP Stock Is on Investors’ Radar Today BXP (BXP) shares have recently shown mixed short term performance, with a gain of about 4% over the past week and roughly 15% over the past month, while the past 3 months remain weaker. See our latest analysis for BXP. At a share price of $59.84, BXP’s recent 15.3% 1 month share price return contrasts with its weaker year to date performance and slightly negative 1 year total shareholder return of 2.0%. This suggests momentum has picked up after a...
NasdaqGS:CRUS
NasdaqGS:CRUSSemiconductor

Why Cirrus Logic (CRUS) Is Up 6.6% After Record FY26 Results And Higher R&D Plans

Cirrus Logic, Inc. has reported past fourth-quarter 2026 results, with revenue rising to US$448.52 million and net income to US$81.81 million, lifting diluted EPS from continuing operations to US$1.56 from US$1.31 a year earlier. Beyond the quarterly beat, management underscored record full-year revenue of about US$2.00 billion, a cash balance near US$1.20 billion with no debt, and US$280 million returned to shareholders via buybacks, alongside guiding fiscal Q1 2027 revenue to US$430–490...
NYSEAM:SEB
NYSEAM:SEBFood

Seaboard (SEB) Margin Rebound to 5.9% Challenges Longstanding Earnings Bear Case

Seaboard's Q1 2026 Earnings Snapshot Seaboard (SEB) opened 2026 with Q1 total revenue of US$2.4b, basic EPS of US$124.24 and net income of US$119m, setting a fresh reference point against last year’s sharp earnings rebound. Over recent quarters the company has seen quarterly revenue move from US$2.316b in Q1 2025 to around the US$2.4b range in Q1 2026. Basic EPS shifted from US$32.95 to US$124.24. Trailing twelve month EPS reached US$606.79 alongside net income of US$583m on US$9.83b of...
NYSE:RYAM
NYSE:RYAMChemicals

Rayonier Advanced Materials (RYAM) Q1 Loss Worsening Pressures Bullish Margin Recovery Narratives

Rayonier Advanced Materials (RYAM) opened 2026 with Q1 revenue of US$319 million and a basic EPS loss of US$1.21, alongside trailing 12 month revenue of about US$1.4 billion and a basic EPS loss of US$7.08. Over recent quarters the company has seen revenue move from US$422.5 million in Q4 2024 to US$355.9 million in Q1 2025, US$340.0 million in Q2 2025, US$352.8 million in Q3 2025, US$417.5 million in Q4 2025 and now US$319 million in Q1 2026, while quarterly basic EPS losses have ranged...
NYSE:DVN
NYSE:DVNOil and Gas

Devon Energy (DVN) Margin Squeeze And EPS Drop Test Bullish Efficiency Narrative

Devon Energy (DVN) opened 2026 with Q1 revenue of US$4.3b and basic EPS of US$0.19 on net income of US$120m, setting a cautious tone for the new year. Over the past few quarters, the company has seen revenue move between US$3.8b and US$4.3b, while quarterly EPS has ranged from about US$0.77 to US$1.42. This has contributed to trailing twelve month EPS of US$3.63 on revenue of US$16.0b. Investors are therefore likely to focus on how much of that top line converts into profit as margins adjust...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

Grab Holdings (NasdaqGS:GRAB) Net Margin Breakout Tests Bullish Profitability Narrative

Grab Holdings (NasdaqGS:GRAB) opened 2026 with Q1 revenue of US$955 million and basic EPS of US$0.03, setting a clear marker for how its ride hailing and delivery platform is currently translating scale into per share earnings. The company has seen quarterly revenue move from US$773 million in Q1 2025 to US$955 million in Q1 2026, while basic EPS has shifted from US$0.01 to US$0.03 over the same period. Trailing twelve month EPS now sits at US$0.09 on revenue of US$3.6 billion, giving...
NYSE:ALLE
NYSE:ALLEBuilding

Allegion (ALLE) Valuation Check After Q1 2026 Results And Upgraded Revenue Guidance

Allegion (ALLE) is back in focus after reporting first quarter 2026 results with sales of US$1,033.6m and net income of US$138.1m, along with higher full year revenue growth guidance incorporating its recent DCI acquisition. See our latest analysis for Allegion. Allegion’s recent earnings update and higher full year revenue guidance come after a 90 day share price return of 23.03% decline and a year to date share price return of 15.9% decline, while the 3 year total shareholder return of...
NYSE:RITM
NYSE:RITMMortgage REITs

A Look At Rithm Capital (RITM) Valuation After Q1 2026 Earnings And Acquisition-Driven Growth

Rithm Capital (RITM) has drawn fresh attention after reporting first quarter 2026 earnings, with sales of US$191.69 million, net income of US$102.68 million, and diluted earnings per share of US$0.12. See our latest analysis for Rithm Capital. At a share price of US$9.84, Rithm Capital has a 1-month share price return of 2.07% but a 90-day share price decline of 8.38%, while the 3-year total shareholder return of 65.27% points to stronger long term compounding. If Rithm’s recent earnings have...
NasdaqGS:BVS
NasdaqGS:BVSMedical Equipment

Bioventus (BVS) Q1 EPS Holds Profitability But Tests Bullish Margin Narratives

Bioventus (BVS) opened 2026 with Q1 revenue of US$132.1 million and basic EPS of US$0.05, alongside trailing twelve month revenue of US$576.3 million and basic EPS of US$0.43 that reflect a period of positive net income. Over recent quarters the company has seen revenue range from US$123.9 million to US$157.9 million, while basic EPS moved from a loss of US$0.04 in early 2025 to US$0.22 in Q4 2025 and US$0.05 in the latest quarter, setting up a narrative that now hinges on how durable these...